NCT01412229 - Induction Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

June 20, 2015

Study Completion Date

December 31, 2019

Conditions

Head and Neck Cancer

Interventions

DRUG

Cetuximab

Weekly cetuximab given intravenously for 6 weeks during induction chemotherapy and continue during the 2-3 week break prior to definitive chemoradiotherapy.

DRUG

Nab-paclitaxel

Weekly nab-paclitaxel given intravenously following cetuximab infusion for 6 weeks.

DRUG

Carboplatin

Weekly carboplatin given intravenously following nab-paclitaxel infusion for 6 weeks.

Trial Locations (3)

27599

University of North Carolina at Chapel Hill, Chapel Hill

37232

Vanderbilt University, Nashville

98194

University of Washington, Seattle